日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Coronary Artery Disease Risk Assessment by Coronary Artery Calcium Scoring in Asymptomatic Thai People with Diabetes Mellitus

通过冠状动脉钙化评分评估无症状泰国糖尿病患者的冠状动脉疾病风险

期刊:Vascular Health and Risk Management
影响因子:2.8
doi:10.2147/VHRM.S582744
Thewjitcharoen, Yotsapon; Chatchomchuan, Waralee; Wanothayaroj, Ekgaluck; Butadej, Siriwan; Nakasatien, Soontaree; Himathongkam, Thep
糖尿病
代谢
发表日期：2026
文献求助 收藏

Sodium-Glucose Cotransporter-2 inhibitor (SGLT2i) Prescription Rates Amongst Diabetologists for Type 2 Diabetes Patients with Albuminuric Diabetic Kidney Disease: A Real-World Study at a Diabetes Center in Bangkok

曼谷一家糖尿病中心的真实世界研究：糖尿病专科医生对伴有蛋白尿的2型糖尿病肾病患者的钠-葡萄糖协同转运蛋白2抑制剂（SGLT2i）处方率

期刊:Journal of the ASEAN Federation of Endocrine Societies
影响因子:1.2
doi:10.15605/jafes.040.02.22
Chongvoranond, Peachaphol; Thewjitcharoen, Yotsapon; Chatchomchaun, Waralee; Wanothayaroj, Ekgaluck; Butadej, Siriwan; Nakasatien, Soontaree; Krittiyawong, Sirinate; Himathongkam, Thep
SGLT2
糖尿病
糖尿病肾病
代谢
发表日期：2025
文献求助 收藏

Prevalence and characteristics of misdiagnosed adult-onset type 1 diabetes mellitus in Thai people by random plasma C-peptide testing

通过随机血浆C肽检测，分析泰国人群中误诊为成人发病型1型糖尿病的患病率和特征

期刊:Heliyon
影响因子:3.6
doi:10.1016/j.heliyon.2023.e14262
Thewjitcharoen, Yotsapon; Soontaree, Nakasatien; Waralee, Chatchomchuan; Siriwan, Butadej; Sirinate, Krittiyawong; Ekgaluck, Wanothayaroj; Thep, Himathongkam
糖尿病
代谢
发表日期：2023
文献求助 收藏

Real-World Use of Once-Weekly Semaglutide in Thai Patients With Type 2 Diabetes Mellitus in a Private Hospital Setting

在泰国私立医院环境中，每周一次使用司美格鲁肽治疗2型糖尿病患者的真实世界研究

期刊:Journal of the ASEAN Federation of Endocrine Societies
影响因子:1.2
doi:10.15605/jafes.038.01.11
Thewjitcharoen, Yotsapon; Yenseung, Nalin; Butadej, Siriwan; Nakasatien, Soontaree; Chotwanvirat, Phawinpon; Chatchomchuan, Waralee; Wanothayaroj, Ekgaluck; Krittiyawong, Sirinate; Himathongkam, Thep
糖尿病
代谢
发表日期：2023
文献求助 收藏

PSAT342 Hypothyroidism After Use Of Immune Checkpoint Inhibitor Therapy In Patient With Graves’ Disease

PSAT342 格雷夫斯病患者使用免疫检查点抑制剂治疗后出现甲状腺功能减退症

期刊:Frontiers in Endocrinology
影响因子:4.6
doi:10.3389/fendo.2021.654638
Yang, Jing; Gong, Rixiang; Ma, Yu; Gao, Jun; Li, Zhihui; Zhu, Jingqiang; Gong, Yanping; Cameira, M; Abreu, P; Pereira, M; Soares, M; Vidó, I; Lopes, I; Abdelhameed, Aya; Mortagy, Mohamed; Elsandouby, Ahmed; Ghaffar, Adeel; Bulchandani, Sheetal; Janicic-Kahric, Natasha; Thewjitcharoen, Yotsapon; Nakasatien, Soontaree; Butadej, Siriwan; Veerasomboonsin, Veekij; Himathongkam, Thep; Sharma, Rajeev
Checkpoint
甲状腺功能减退
PSA
免疫/内分泌
发表日期：2022
文献求助 收藏

Duration of antithyroid drug treatment may predict weight gain after radioactive iodine therapy in patients with Graves' disease

抗甲状腺药物治疗的持续时间可能预测格雷夫斯病患者接受放射性碘治疗后的体重增加情况。

期刊:Heliyon
影响因子:3.6
doi:10.1016/j.heliyon.2022.e09471
Yotsapon, Thewjitcharoen; Waralee, Chatchomchuan; Hussamon, Prasatkaew; Panita, Srichomchey; Siriwan, Butadej; Soontaree, Nakasatien; Ekgaluck, Wanothayaroj; Rajata, Rajatanavin; Thep, Himathongkam
免疫/内分泌
发表日期：2022
文献求助 收藏

Implementation of diabetes care and educational program via telemedicine in patients with COVID-19 in home isolation in Thailand: A real-worldexperience

在泰国，通过远程医疗为居家隔离的新冠肺炎患者实施糖尿病护理和教育计划：一项真实案例研究

期刊:Journal of Diabetes Investigation
影响因子:3
doi:10.1111/jdi.13804
Harindhanavudhi, Tasma; Areevut, Chatvara; Sahakitrungruang, Taninee; Tharavanij, Thipaporn; Kietdumrongwong, Pongtorn; Ngimruksa, Orasa; Songsiri, Patitta; Pitukweerakul, Siwadon; Tanathornkirati, Nattamon; Kaewprasert, Natthapon; Thamcharoen, Ruchirek; Karndumri, Krittadhee; Saetung, Sunee; Anthanont, Pimjai; Kiattisakthavee, Pornpimol; Putkong, Sarapee; Chotwanvirat, Phawinpon; Nartsupha Phattanasri, Chorthip; Jinadit, Srikorn; Korpaisarn, Sira; Chusane, Manusvinee; Samittarucksa, Rattanapan; Lertrit, Amornpan; Siangruangsang, Sanguansak; Sanpawithayakul, Kanokporn; Sathiravikarn, Waraporn; Soisuwan, Sataporn; Chevaisrakul, Parawee; Imsakul, Kanokporn; Thuptimtong, Pinradakarn; Sakmanarit, Jandanee; Somwang, Supaporn; Prasartkaew, Hussamon; Jerawatana, Ratanaporn; Butadej, Siriwan; Tachanivate, Porntip; Jongjaroenprasert, Wallaya; Sripatong, Jeeraphan; Chobtangsilp, Sunanta; Kamnirdsittiseree, Pattraphorn; Savetkairop, Benjaporn; Manosittisak, Warot; Tantivatanasatien, Jitra; Hathaidechadusadee, Amornrat; Reutrakul, Sirimon
肺炎
新冠
代谢
微生物学
糖尿病
发表日期：2022
文献求助 收藏

Profile of Levothyroxine Replacement Therapy in Graves' Disease Patients with Hypothyroidism Post-Radioactive Iodine Ablation: Focus on Different Weight-Based Regimens

放射性碘消融术后伴甲状腺功能减退的格雷夫斯病患者左甲状腺素替代疗法概况：重点关注不同的基于体重的治疗方案

期刊:Journal of the ASEAN Federation of Endocrine Societies
影响因子:1.2
doi:10.15605/jafes.037.01.19
Mathiphanit, Saravut; Yenseung, Nalin; Chatchomchuan, Waralee; Butadej, Siriwan; Nakasatien, Soontaree; Wanothayaroj, Ekgaluck; Rajatanavin, Rajata; Himathongkam, Thep; Thewjitcharoen, Yotsapon
甲状腺功能减退
免疫/内分泌
发表日期：2022
文献求助 收藏

Impacts of the American Joint Committee on Cancer (AJCC) 8(th) edition tumor, node, metastasis (TNM) staging system on outcomes of differentiated thyroid cancer in Thai patients

美国癌症联合委员会（AJCC）第8版肿瘤、淋巴结、转移（TNM）分期系统对泰国分化型甲状腺癌患者预后的影响

期刊:Heliyon
影响因子:3.6
doi:10.1016/j.heliyon.2021.e06624
Thewjitcharoen, Yotsapon; Chatchomchuan, Waralee; Karndumri, Krittadhee; Porramatikul, Sriurai; Krittiyawong, Sirinate; Wanothayaroj, Ekgaluck; Butadej, Siriwan; Nakasatien, Soontaree; Veerasomboonsin, Veekij; Kanchanapituk, Auchai; Rajatanavin, Rajata; Himathongkam, Thep
甲状腺癌
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2021
文献求助 收藏

Practice patterns and outcomes in the management of Thai patients with Graves' disease

泰国格雷夫斯病患者的诊疗模式和治疗结果

期刊:Thyroid Research
影响因子:1.8
doi:10.1186/s13044-021-00097-y
Thewjitcharoen, Yotsapon; Karndumri, Krittadhee; Chatchomchuan, Waralee; Porramatikul, Sriurai; Krittiyawong, Sirinate; Wanathayanoroj, Ekgaluck; Lekpittaya, Nampetch; Kittipoom, Worawit; Anuntakulnatee, Tawee; Vongterapak, Somboon; Butadej, Siriwan; Nakasatien, Soontaree; Rajatanavin, Rajata; Himathongkam, Thep
发表日期：2021
文献求助 收藏